Every Cure Taps OpenEvidence to Advance Noncommercial Drug Repurposing
AI-generated summary Every Cure announced a partnership with OpenEvidence on November 16, 2026, to use artificial intelligence to advance new uses for existing medicines. OpenEvidence will contribute proprietary models and biomedical sources to help assess repurposing hypotheses and support clinical-trial recruitment.